More answers like this
Grok 4.5Oct 20, 2026x-ai/grok-4.5-20260708

Is the US prepared to deal with another pandemic or widespread health crisis?

No, the US is not fully prepared for another pandemic or widespread health crisis, though it has made meaningful improvements in some areas since COVID-19. Significant gaps remain in coordination, funding, leadership, public health infrastructure, trust, and equity, and recent policy shifts appear to have weakened defenses further.[1][2]

Assessments from nonpartisan and bipartisan sources paint a mixed but concerning picture. The US ranked highly on paper pre-COVID (e.g., Global Health Security Index) yet performed poorly in practice due to testing failures, supply shortages, fragmented response, inequities, and eroded trust. Lessons from that experience have driven some progress, but implementation is incomplete, and vulnerabilities persist—or have grown.

Key Improvements Since COVID-19

•Stockpiles and countermeasures: The Strategic National Stockpile (SNS) was substantially restocked (e.g., far higher levels of N95s, gloves, gowns, and ventilators). BARDA and related efforts advanced medical countermeasures, including platforms for faster vaccine/therapeutic development. The SNS has supported responses to H5N1, mpox, and other threats.[3][4]
•Surveillance and data: Major expansions in electronic case reporting (from under 200 facilities pre-COVID to over 45,000–48,000 by late 2024), syndromic surveillance (most hospital EDs), wastewater monitoring, and other tools for earlier detection. CDC created “warm base” lab partnerships and improved forecasting.[5][3]
•Coordination structures: Creation of the White House Office of Pandemic Preparedness and Response Policy (OPPR) in 2023; updates to biodefense strategies and policies (including dual-use research oversight); investments in global health security (billions since 2020, though later impacted).[6][7]
•Other: Faster vaccine/treatment scale-up demonstrated (mRNA platforms, etc.); some state-level gains like expanded nurse licensure compacts for surge staffing; ASPR/BARDA continued MCM approvals and deployments.[8]

Biden administration reports (e.g., 2025 roadmap) highlighted these as transforming readiness, alongside equitable access efforts and global contributions.[3]

Persistent and Ongoing Gaps

•GAO findings: As of mid-2024, of ~428 recommendations related to COVID lessons, ~220 remained open. High-risk areas include HHS leadership/coordination of public health emergencies, data sharing, supply chain resilience, planning, and communication. Lessons span advanced planning, partner collaboration, clear communications, program integrity, data, leveraging infrastructure, and flexibilities.[9][9]
•Bipartisan Commission on Biodefense (2024 National Blueprint): The nation “remains dangerously vulnerable.” Biological threats (natural, accidental, deliberate) are real and growing. Key needs include stronger White House leadership (e.g., codifying National Security Advisor role + deputy for biodefense), a unified budget/quadrennial review and updated strategy, better detection (replace ineffective BioWatch), science/tech investment, preparedness across the spectrum, and sustained (“on all the time”) effort rather than boom-bust. It offered 36 recommendations and 185 action items; some prior ones were adopted, but far from enough.[1][10][11]
•State and local readiness (TFAH Ready or Not reports): In 2025 assessments, only ~21 states + DC in high tier; many in middle/low. Issues include public health funding cuts in multiple states (linked to expiring COVID funds and federal reductions), low flu vaccination (~47% in one recent season, far below goals), limited paid sick leave access, high avoidable mortality (with disparities), and variable lab surge capacity/healthcare readiness. All states have room to improve; compounding threats (infectious disease + extreme weather) strain systems. Similar patterns held in later updates.[8][8][12]
•Funding and authorities: Gaps between authorized needs (e.g., PHEMCE estimates) and appropriations; PAHPA reauthorization/modernization delays or lapses; workforce shortages and burnout; supply chain vulnerabilities; antimicrobial resistance; and healthcare access/equity issues that amplify crises.[13]
•Other weaknesses: Ambiguous federal-state authorities/turf issues; eroded public trust in institutions/guidance (a major COVID failure factor); incomplete implementation of recommendations on testing strategies, MCM manufacturing, and indoor air/pathogen reduction; and challenges with concurrent disasters.[14]

Recent Developments and Expert Concerns (Post-2024)

Under the subsequent administration, experts and reports describe setbacks: significant CDC staffing reductions (reports of ~25%/thousands of positions, including key expertise); NIH/NIAID strategic shifts away from biodefense, emerging infectious diseases, and pandemic preparedness research (with some funds redirected); US withdrawal from WHO; cuts or wind-downs to mRNA and other countermeasure projects; understaffing or unclear status of OPPR; and reduced global health security engagement/funding. Critics (including former officials and researchers) argue this leaves the US “much less prepared” than during or just after COVID, or even 2020 levels in key areas, at a time of ongoing threats like H5N1.[15][16][17][18]

ASPR continues operational work (stockpile use, training, some MCM progress, responses to outbreaks/disasters), but broader capacity is strained.[19][20]

Bottom Line and What Would Help

The US has better tools in specific domains (detection tech, stockpiles, rapid-response platforms) than in 2019 and demonstrated capacity to innovate under pressure. However, it lacks the sustained political will, unified leadership, stable funding, resilient workforce/infrastructure, high public trust, and fully implemented reforms needed for a high-confidence response to a novel, highly transmissible/severe pathogen—or a deliberate attack. State variation means some areas would fare better than others. Concurrent threats (climate-driven disasters, AMR, etc.) compound risks.

Experts consistently call for: sustained/flexible public health funding (domestic + global); clear White House-led coordination and authorities; PAHPA modernization/reauthorization with adequate appropriations; investment in workforce, labs, surveillance, and MCM R&D/manufacturing (including domestic capacity); equity-focused community resilience; and rebuilding trust through transparent communication. Without these, the next crisis risks repeating or exceeding COVID-scale impacts.[2][21]

Preparedness is a continuous process, not a one-time achievement. Current trajectory, per multiple independent reviews, falls short of what is required.

Citations (21)

  1. 1biodefensecommission.orgNonprofits and think tanks
    https://biodefensecommission.org/reports/the-national-blueprint-for-biodefense/

    Backs: “Significant gaps remain in coordination, funding, leadership, public health infrastructure, trust, and equity, and recent policy shifts appear to have weakened defenses further.”

  2. 2stimson.orgNonprofits and think tanks
    https://www.stimson.org/2024/prepare-for-the-next-biothreat-now/

    Backs: “Significant gaps remain in coordination, funding, leadership, public health infrastructure, trust, and equity, and recent policy shifts appear to have weakened defenses further.”

  3. 3archives.govGovernment
    https://bidenwhitehouse.archives.gov/briefing-room/statements-releases/2025/01/14/report-the-biden-harris-administration-roadmap-for-pandemic-preparedness-and-response/

    Backs: “The SNS has supported responses to H5N1, mpox, and other threats.”

  4. 4apnews.comNews and mediaquality 1.00
    https://apnews.com/article/pandemic-preparedness-trump-biden-192518a8e1414cf40bafefdc2bf1f5ca

    Backs: “The SNS has supported responses to H5N1, mpox, and other threats.”

  5. 5cdc.govGovernment
    https://www.cdc.gov/washington/testimony/2024/t20241114.htm

    Backs: “CDC created “warm base” lab partnerships and improved forecasting.”

  6. 6ucsb.eduAcademic
    https://www.presidency.ucsb.edu/documents/fact-sheet-biden-harris-administration-releases-global-health-security-annual-report

    Backs: “Creation of the White House Office of Pandemic Preparedness and Response Policy (OPPR) in 2023; updates to biodefense strategies and policies (including dual-use research oversight); investments in global health security (billions since 2020, though later impacted).”

  7. 7ucsb.eduAcademic
    https://www.presidency.ucsb.edu/documents/report-the-biden-harris-administration-roadmap-for-pandemic-preparedness-and-response

    Backs: “Creation of the White House Office of Pandemic Preparedness and Response Policy (OPPR) in 2023; updates to biodefense strategies and policies (including dual-use research oversight); investments in global health security (billions since 2020, though later impacted).”

  8. 8tfah.orgNonprofits and think tanks
    https://www.tfah.org/article/new-report-measures-states-preparedness-for-public-health-emergencies-including-infectious-disease-outbreaks-and-extreme-weather-events/

    Backs: “Faster vaccine/treatment scale-up demonstrated (mRNA platforms, etc.); some state-level gains like expanded nurse licensure compacts for surge staffing; ASPR/BARDA continued MCM approvals and deployments.”

  9. 9gao.govGovernment
    https://www.gao.gov/products/gao-24-107175

    Backs: “Lessons span advanced planning, partner collaboration, clear communications, program integrity, data, leveraging infrastructure, and flexibilities.”

  10. 10biodefensecommission.orgNonprofits and think tanks
    https://biodefensecommission.org/wp-content/uploads/2024/05/National-Blueprint-for-Biodefense-2024_final_.pdf

    Backs: “It offered 36 recommendations and 185 action items; some prior ones were adopted, but far from enough.”

  11. 11axios.comNews and mediaquality 0.90
    https://www.axios.com/2024/05/07/biodefense-buildup-urged-exclusive-report

    Backs: “It offered 36 recommendations and 185 action items; some prior ones were adopted, but far from enough.”

  12. 12tfah.orgNonprofits and think tanks
    https://www.tfah.org/report-details/ready-or-not-2026/

    Backs: “All states have room to improve; compounding threats (infectious disease + extreme weather) strain systems. Similar patterns held in later updates.”

  13. 13center-forward.orgNonprofits and think tanks
    https://center-forward.org/basic/pandemic-preparedness-strengthening-the-u-s-response-framework-2/

    Backs: “PAHPA reauthorization/modernization delays or lapses; workforce shortages and burnout; supply chain vulnerabilities; antimicrobial resistance; and healthcare access/equity issues that amplify crises.”

  14. 14nejm.orgAcademic
    https://www.nejm.org/doi/full/10.1056/NEJMp2406427

    Backs: “Ambiguous federal-state authorities/turf issues; eroded public trust in institutions/guidance (a major COVID failure factor); incomplete implementation of recommendations on testing strategies, MCM manufacturing, and indoor air/pathogen reduction; and challenges with concurrent disasters.”

  15. 15straitstimes.comNews and mediaquality 0.75
    https://www.straitstimes.com/world/united-states/is-the-us-prepared-for-the-next-pandemic-how-trumps-policies-have-weakened-defences

    Backs: “Critics (including former officials and researchers) argue this leaves the US “much less prepared” than during or just after COVID, or even 2020 levels in key areas, at a time of ongoing threats like H5N1.”

  16. 16the-scientist.comNot yet classified
    https://www.the-scientist.com/niaid-moves-away-from-biodefense-experts-are-worried-75109

    Backs: “Critics (including former officials and researchers) argue this leaves the US “much less prepared” than during or just after COVID, or even 2020 levels in key areas, at a time of ongoing threats like H5N1.”

  17. 17science.orgAcademic
    https://www.science.org/content/article/trump-administration-dismantling-efforts-fight-next-pandemic

    Backs: “Critics (including former officials and researchers) argue this leaves the US “much less prepared” than during or just after COVID, or even 2020 levels in key areas, at a time of ongoing threats like H5N1.”

  18. 18infectioncontroltoday.comNot yet classified
    https://www.infectioncontroltoday.com/view/opinion-us-biodefense-policy-scrutiny-nih-cdc-pandemic-preparedness-programs-face-cuts

    Backs: “Critics (including former officials and researchers) argue this leaves the US “much less prepared” than during or just after COVID, or even 2020 levels in key areas, at a time of ongoing threats like H5N1.”

  19. 19aspr.govGovernment
    https://www.aspr.gov/

    Backs: “ASPR continues operational work (stockpile use, training, some MCM progress, responses to outbreaks/disasters), but broader capacity is strained.”

  20. 20aspr.govGovernment
    https://www.aspr.gov/news-updates/blog/2025-12/stand-ready-move-fast-save-lives

    Backs: “ASPR continues operational work (stockpile use, training, some MCM progress, responses to outbreaks/disasters), but broader capacity is strained.”

  21. 21commonwealthfund.orgNonprofits and think tanks
    https://www.commonwealthfund.org/blog/2023/lessons-covid-19-can-help-us-prepare-next-pandemic

    Backs: “Without these, the next crisis risks repeating or exceeding COVID-scale impacts.”